Geographic Expansionprimary sourcedetected 2026-06-11 · confidence 90%
Lumos Diagnostics: Geographic Expansion
Lumos Diagnostics expanded FebriDx adoption across 100+ US healthcare sites following CLIA Waiver approval, significant US market penetration
Source: GN — ASX:LDX Lumos Diagnostics
The leadership read
Likely need for Regional Sales Managers, Account Executives for healthcare sector, Clinical Affairs specialists, Regulatory Affairs professionals, and Customer Success Managers to support rapid US expansion and site onboarding
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Oceania signal share is rising (+13.1pts).